本システムでは、JavaScriptを利用しています。JavaScriptを有効に設定してからご利用ください。
Skip to main content
Contact Us
FONT SIZE
normal
large
LANGUAGE
JP
EN
HOME
About ASKA Pharmaceutical Holdings
Top Message
Corporate Philosophy
Company Overview
Charter of Corporate Behavior
Board Members and Corporate Officers
Group Companies
Business Activities
Corporate History
Organization Chart
ASKA Pharmaceutical Holdings in Numbers
Policies
Access Map
For Our Shareholders and Investors
IR News
IR Library
IR Calendar
Management Strategies and Policies
Governance
Pipeline
Financial Highlights
ASKA Pharmaceutical Holdings at a glance
Stock Information
Disclaimer
IR E-mail Newsletter Service
IR Site Map
Recommended Route to Access Our IR Website
Sustainability
Our Sustainability
Environmental
Social
Governance
ESG Chart and ESG Data Book
Integrated Report
External Evaluation
Initiatives and Member Organizations
Third-party Opinion
Press Releases
Contact Us
Privacy Policy
Basic Policy on the Proper Handling of Specific Personal Information, etc.
Terms of Use
Site Policy
Cookie Policy
SNS コミュニティ・ガイドライン
公式Webサイト・SNS
Sitemap
About ASKA Pharmaceutical Holdings
Company Overview
Group Companies
Top Message
Corporate Philosophy
Company Overview
Charter of Corporate Behavior
Board Members and Corporate Officers
Group Companies
Business Activities
Corporate History
Organization Chart
ASKA Pharmaceutical Holdings in Numbers
Policies
Access Map
For Our Shareholders and Investors
Top Message
Medium-Term Management Plan
ASKA Pharmaceutical Holdings at a glance
IR News
IR Library
IR Calendar
Management Strategies and Policies
Governance
Pipeline
Financial Highlights
ASKA Pharmaceutical Holdings at a glance
Stock Information
Disclaimer
IR E-mail Newsletter Service
IR Site Map
Recommended Route to Access Our IR Website
Sustainability
Integrated Report
Our Basic Policy for Sustainability
Various Contrasting Tables
Our Sustainability
Top Commitment
Our Basic Policy for Sustainability
Materiality
Value Creation Process
Initiatives for Sustainability and SDGs
Disclosures based on TCFD recommendations
Various Contrasting Tables
Sustainability News
Policies
Environmental
Social
Governance
ESG Chart and ESG Data Book
Integrated Report
External Evaluation
Initiatives and Member Organizations
Third-party Opinion
HOME
>
HOME
>
For Our Shareholders and Investors
>
Stock Information
>
Stock summary information
Stock summary information
PRINT
Stock summary information
(As of March 31, 2024)
Securities code
4886
Listing
Tokyo Stock Exchange (TSE Prime)
Listing date
April 1, 2021
Businesses
Pharmaceuticals
Number of shares per unit
100
Total authorized shares
90,000,000
Shares issued
30,563,199
Business year
From April1 to March 31 of the next year
Annual general meeting of shareholders
Held in June every year
Record date of shareholders eligible for profit dividends
March 31
Record date of shareholders eligible for interim dividends
September 30
Transfer Agent and Registrars
Mitsubishi UFJ Trust and Banking Corporation
Stock related procedures
In case you have an account with your securities company:
Your securities company will be the contact for any change of registration.
For special account:
Please contact the inquiry desk indicated below.
11-10, Higashisuna 7-chome, Koto-ku, Tokyo 137-8081, Japan
Stock Transfer Agency Department, Mitsubishi UFJ Trust and Banking Corporation
Tel. 0120-232-711 (toll-free service from within Japan)
Method of public notice
The Company's main method of issuing public notice is electronic. However, public notices are published in the Nihon Keizai Shimbun newspaper when an electronic public notice cannot be given due to an accident or other unavoidable circumstance.
Equity index funds
TOPIX Small2 (As of September 11, 2023)
FTSE Blossom Japan Index (As of July 24, 2023)
FTSE Blossom Japan Sector Relative Index (As of July 24, 2023)
S&P/JPX Carbon Efficiency Index (As of June 19, 2023)
Audit Firm
Seiyo Audit Corporation
Book Runner
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
Total number of shareholders
6,769 (as of March 31, 2024)
Number of shareholders with voting rights
5,836 (as of March 31, 2024)
Notice
1.
In accordance with the dematerialization of stock certificates, various procedures related to stock including change of address, request for purchase or sale will be, in principle, handled at the account management institution (securities company, etc.) with which you maintain the account. Please contact the securities company where the account was opened for these procedures. Note that these procedures are not offered by the administrator of the shareholder registry (Mitsubishi UFJ Trust and Banking Corporation).
2.
Procedures related to the stock recorded in a special account are managed by Mitsubishi UFJ Trust and Banking Corporation as the account management institution. Please inquire at the account management institution (Mitsubishi UFJ Trust and Banking Corporation) for special accounts listed above. In addition, these procedures are also handled at all Mitsubishi UFJ Trust and Banking Corporation branches in Japan.
3.
Non-received dividends will be paid through the main and branch offices of Mitsubishi UFJ Trust and Banking Corporation.
About ASKA Pharmaceutical Holdings
Top Message
Corporate Philosophy
Company Overview
Charter of Corporate Behavior
Board Members and Corporate Officers
Group Companies
Business Activities
Corporate History
Organization Chart
ASKA Pharmaceutical Holdings in Numbers
Policies
Access Map
For Our Shareholders and Investors
IR News
IR Library
IR Library
Financial Results
Annual Securities Report
Integrated Report
Shareholder Newsletters (Japanese version only)
Shareholders' Meeting
Fact Sheet
IR Calendar
Management Strategies and Policies
Management Strategies and Policies
Top Message
Medium-Term Management Plan
Business Risks
Disclosure Policy
Governance
Governance
Basic Principles / Corporate Governance Structure
Corporate Governance Basic Policy
Corporate Governance Report (Japanese version only)
Board Members
Compliance / Risk Management
Internal Control System
Material Issues: G
ESG Chart and ESG Data Book
Pipeline
Financial Highlights
Financial Highlights
Performance Review
Performance Highlights
Financial Conditions
Financial Statements
Consolidated Balance Sheets
Consolidated Statements of Income
Consolidated Statements of Cash Flows
Earnings Forecast
Non-Financial Highlights (ESG Chart and ESG Data Book)
ASKA Pharmaceutical Holdings at a glance
ASKA Pharmaceutical Holdings at a glance
Point1 About ASKA - Understanding & History -
Point2 About ASKA - Our Strengths -
Point3 Highly Specialized Product Lineup
Point4 Continuously Evolving R&D
Point5 Stable Shareholder Returns
Frequently Asked Questions
Stock Information
Stock Information
Stock summary information
Shareholder Information
Shareholders' Meeting
Stock Price Information
Dividends and Dividend Payout Ratio
Articles of Incorporation and Stock Handling Regulations
Analyst Coverage
Disclaimer
IR E-mail Newsletter Service
IR Site Map
Recommended Route to Access Our IR Website
Sustainability
Our Sustainability
Our Sustainability
Top Commitment
Our Basic Policy for Sustainability
Materiality
Value Creation Process
Initiatives for Sustainability and SDGs
Disclosures based on TCFD recommendations
Various Contrasting Tables
Sustainability News
Policies
Environmental
Environmental
Basic Environmental Philosophy / Environmental Policies
Material Issues: E
Disclosures Based on TCFD Recommendations
Decarbonization Initiatives
Initiatives for Water Resource
Initiatives for Recycle-Oriented Society and Biodiversity
ESG Chart and ESG Data Book
Environmental Management
Social
Social
Respect for Human Rights
Labour Practices
Diversity & Inclusion
Initiatives to Promote the Advancement of Women
Health Management Initiatives
Fair Operating Practices
Supply Chain
Customer Health and Safety
Social Contribution Activities(Community Involvement and Development)
Material Issues: S
ESG Chart and ESG Data Book
Governance
ESG Chart and ESG Data Book
Integrated Report
External Evaluation
Initiatives and Member Organizations
Third-party Opinion
Press Releases
Contact Us
Privacy Policy
Basic Policy on the Proper Handling of Specific Personal Information, etc.
Terms of Use
Site Policy
Cookie Policy
SNS コミュニティ・ガイドライン
公式Webサイト・SNS
Sitemap
TOP